{"content":"<li class=\"n-box-item date-title\" data-end=\"1568433599\" data-start=\"1568347200\" data-txt=\"Monday, December 23, 2019\">Friday, September 13, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3499338\" data-ts=\"1568412406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KDMN\" target=\"_blank\">KDMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499338-kadmonminus-2_5-after-mixed-shelf-shareholder-registration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kadmon -2.5% after mixed shelf, shareholder registration</a></h4><ul>   <li>Kadmon Holdings (NYSE:<a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings, Inc.'>KDMN</a>) is <font color=\"red\">2.5% lower</font> after hours following a <a href=\"https://seekingalpha.com/filing/4635201\" target=\"_blank\">$200M mixed shelf registration</a> and a secondary filing for holders to offer up to 7.34M shares.</li>    <li>Of the secondary, 4.88M shares are registered common stock, and 2.46M shares of common stock would be issued upon conversion of 5% convertible preferred stock.</li>    <li>The company won't receive any proceeds from any sales by the selling stockholders.</li>    <li>Those selling stockholders include major holders Perceptive Life Sciences Master Fund and Third Point Loan LLC, as well as GoldenTree 2004 Trust.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499338\" data-linked=\"Kadmon -2.5% after mixed shelf, shareholder registration\" data-tweet=\"$KDMN - Kadmon -2.5% after mixed shelf, shareholder registration https://seekingalpha.com/news/3499338-kadmonminus-2_5-after-mixed-shelf-shareholder-registration?source=tweet\" data-url=\"https://seekingalpha.com/news/3499338-kadmonminus-2_5-after-mixed-shelf-shareholder-registration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499336\" data-ts=\"1568412397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499336-ego-oas-and-aobc-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EGO, OAS and AOBC among notable after hours movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a> <font color=\"green\">+4.9%</font>. <a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color=\"green\">+2.4%</font>. <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color=\"green\">+1.9%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF S.A.'>BRFS</a> <font color=\"green\">+1.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color=\"red\">-2.9%</font>. <a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a> <font color=\"red\">-2.4%</font>. <a href='https://seekingalpha.com/symbol/CNHI' title='CNH Industrial N.V.'>CNHI</a> <font color=\"red\">-1.8%</font>. <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corporation'>FRAN</a> <font color=\"red\">-1.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499336\" data-linked=\"EGO, OAS and AOBC among notable after hours movers\" data-tweet=\"$CYTK $AOBC $EGO - EGO, OAS and AOBC among notable after hours movers https://seekingalpha.com/news/3499336-ego-oas-and-aobc-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499336-ego-oas-and-aobc-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499290\" data-ts=\"1568406807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMT\" target=\"_blank\">AIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499290-fda-advisory-committee-backs-aimmunes-ar101-for-peanut-allergy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA advisory committee backs Aimmune&#39;s AR101 for peanut allergy</a></h4><ul><li>The FDA's Allergenic Products Advisory Committee voted 7 - 2 backing the efficacy of Aimmune Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics, Inc.'>AIMT</a>) Palforzia (AR101) to reduce the incidence and severity of allergic reactions to peanut in young people aged 4 - 17 who have a confirmed diagnosis of peanut allergy.</li><li><strong>Update</strong>: The committee is discussing a REMS strategy ahead of the safety vote. The agency will require documentation that any patient prescribed Palforzia also has a valid prescription for injectable epinephrine that caregivers and patients must confirm that they are carrying while taking Palforzia and initial dose escalation and the first dose of each up-dosing level must be administered in a certified facility capable of handling systemic allergic reactions. Labeling will include a black box warning.</li><li><strong>Update</strong>: The committee voted 8 - 1 backing safety.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499290\" data-linked=\"FDA advisory committee backs Aimmune&#39;s AR101 for peanut allergy\" data-tweet=\"$AIMT - FDA advisory committee backs Aimmune&#39;s AR101 for peanut allergy https://seekingalpha.com/news/3499290-fda-advisory-committee-backs-aimmunes-ar101-for-peanut-allergy?source=tweet\" data-url=\"https://seekingalpha.com/news/3499290-fda-advisory-committee-backs-aimmunes-ar101-for-peanut-allergy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499318\" data-ts=\"1568406603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499318-nugt-gdxj-jnug-and-jdst-among-weekly-etf-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NUGT, GDXJ, JNUG and JDST among weekly ETF movers</a></h4><ul><li><strong>Gainers: </strong>Ipath US Treasury 10 Yr Bear ETN (BATS:<a href='https://seekingalpha.com/symbol/DTYS' title='iPath US Treasury 10-year Bear ETN'>DTYS</a>) <font color=\"green\">+37.9%</font>.</li><li>Direxion Regional Banks Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DPST' title='Direxion Shares ETF Trust - Direxion Daily Regional Banks Bull 3X Shares'>DPST</a>) <font color=\"green\">+25.1%</font>.</li><li>Direxion Junior Gold Mine Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>) <font color=\"green\">+24.3</font><font color=\"green\">%</font>.</li><li>Ultrapro Short 20+ Year Trsy Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/TTT' title='ProShares Trust - ProShares UltraPro Short 20+ Year Treasury'>TTT</a>) <font color=\"green\">+20.7%</font>.</li><li>20+ Year Trsy Bear 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>) <font color=\"green\">+20.7%</font>.</li><li><strong>Losers: </strong>Direxion Junior Gold Mine Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>) <font color=\"red\">-20.9%</font>.</li><li>Direxion Natural Gas Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>)<font color=\"red\"> -20.0%</font>.</li><li>Gold Miners Bull 3X Direxion ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>) <font color=\"red\">-18.4%</font>.</li><li>Direxion S&amp;P Oil &amp; Gas Expl Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>) <font color=\"red\">-17.9%</font>.</li><li>20+ Year Trsy Bull 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>)<font color=\"red\"> -17.9%</font>.</li><li><strong>Top non-leveraged gainers: </strong>S&amp;P Smallcap 600 Pure Value Invesco ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/RZV' title='Invesco Exchange-Traded Fund Trust - Invesco S&P SmallCap 600 Pure Value ETF'>RZV</a>) <font color=\"green\">+10.4%</font>.</li><li>Steel Vaneck ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>) <font color=\"green\">+10.3%</font>.</li><li>Smallcap Revenue ETF Oppenheimer (NYSEARCA:<a href='https://seekingalpha.com/symbol/RWJ' title='Oppenheimer S&P SmallCap 600 Revenue ETF'>RWJ</a>) <font color=\"green\">+8.8%</font>.</li><li>S&amp;P Metals &amp; Mining SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XME' title='SPDR S&P Metals and Mining ETF'>XME</a>) <font color=\"green\">+8.8%</font>.</li><li>DJ Select Microcap First Trust (NYSEARCA:<a href='https://seekingalpha.com/symbol/FDM' title='First Trust Dow Jones Select MicroCap ETF'>FDM</a>) <font color=\"green\">+8.7%</font>.</li><li><strong>Top non-leveraged losers: </strong>25+ Year Zero Cpn U.S. Trsy Idx ETF Pimco (NYSEARCA:<a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO ETF Trust - PIMCO 25+ Year Zero Coupon U.S. Treasury Index Exchange-Traded Fund'>ZROZ</a>) <font color=\"red\">-9.5%</font>.</li><li>Advisorshares D.W. Short ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/DWSH' title='AdvisorShares Trust - AdvisorShares Dorsey Wright Short ETF'>DWSH</a>) <font color=\"red\">-8.7%</font>.</li><li>Extended Dur Trs Idx ETF Vanguard (NYSEARCA:<a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>) <font color=\"red\">-8.4%</font>.</li><li>DWA Technology Momentum Invesco ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/PTF' title='Invesco Exchange-Traded Fund Trust - Invesco DWA Technology Momentum ETF'>PTF</a>) <font color=\"red\">-8.4%</font>.</li><li>Junior Gold Miners ETF Vaneck (NYSEARCA:<a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>) <font color=\"red\">-7.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499318\" data-linked=\"NUGT, GDXJ, JNUG and JDST among weekly ETF movers\" data-tweet=\"$DTYS $DPST $JDST - NUGT, GDXJ, JNUG and JDST among weekly ETF movers https://seekingalpha.com/news/3499318-nugt-gdxj-jnug-and-jdst-among-weekly-etf-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499318-nugt-gdxj-jnug-and-jdst-among-weekly-etf-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499312\" data-ts=\"1568406016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499312-cloudflare-closes-first-day-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudflare closes first day up 20%</a></h4><ul><li>Cloudflare (NYSE:<a href='https://seekingalpha.com/symbol/NET' title='CloudFlare'>NET</a>) closes its first day of trading <font color=\"green\">up 20%</font> to $18.</li><li>Rival Fastly (NYSE:<a href='https://seekingalpha.com/symbol/FSLY' title='Fastly, Inc.'>FSLY</a>) closed <font color=\"red\">down 3.7%</font> to $29.04.</li><li>Related: Cloudflare started the day at $18 after pricing at $15 and shares traded as high as $19.53 during the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499312\" data-linked=\"Cloudflare closes first day up 20%\" data-tweet=\"$NET $FSLY - Cloudflare closes first day up 20% https://seekingalpha.com/news/3499312-cloudflare-closes-first-day-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3499312-cloudflare-closes-first-day-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499307\" data-ts=\"1568404785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499307-freeport-mcmoran-surges-alongside-copper-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport McMoRan surges alongside copper prices</a></h4><ul><li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color=\"green\">+3.9%</font>) ranks among today's top three gainers on the S&amp;P 500 as copper prices rise, capping a 30%-plus surge since hitting a 52-week low $8.58 on Aug. 27.</li><li>Front-month Comex copper futures hit their highest in a month and a half, <font color=\"green\">+2.2%</font> to $2.699/lb., as investors hoped an easing of U.S.-China trade tensions eventually could lift metals demand.</li><li>FCX has enjoyed an increasing amount of <a href=\"https://seekingalpha.com/article/4291186-higher-copper-prices-lifting-freeport\" target=\"_blank\">bullish options activit</a>y in recent days, Mott Capital Management observes.</li><li>Top global miners Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto Group'>RIO</a> <font color='green'>+2.2%</font>) and (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Group'>BHP</a> <font color='green'>+1.9%</font>) also sport strong gains in today's trade.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJCTF' title='iPath Bloomberg Copper Subindex Total Return ETN'>JJCTF</a>, <a href='https://seekingalpha.com/symbol/COPX' title='Global X Copper Miners ETF'>COPX</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Commodity Index Funds Trust - United States Copper Index Fund'>CPER</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3499307\" data-linked=\"Freeport McMoRan surges alongside copper prices\" data-tweet=\"$FCX $JJCTF $COPX - Freeport McMoRan surges alongside copper prices https://seekingalpha.com/news/3499307-freeport-mcmoran-surges-alongside-copper-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3499307-freeport-mcmoran-surges-alongside-copper-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499303\" data-ts=\"1568403616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499303-investors-re-think-rate-cut-odds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors re-think rate cut odds</a></h4><ul><li>We can probably begin thinking about using the word \"crash\" to describe the action in the bond market over the past two weeks. The 10-year Treasury yield is up another 12.5 basis points today to 1.90% - that's a 45 basis point move since Labor Day.</li><li>Checking the short end, traders are quickly bailing out of long positions in short-dated Eurodollar <a href=\"https://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">and Fed Funds futures</a>. A 25-basis point rate cut this month was a near-metaphysical certainty just days ago (and a 50-basis point cut was under serious debate), but the betting now says there's <strong>more than a 20% chance of no move at all</strong>.</li><li>The Fed's meeting begins next Tuesday, with the decision to be announced Wednesday afternoon. Should be fun.</li><li>Broad U.S. fixed-income ETFs: <a href='https://seekingalpha.com/symbol/PTY' title='PIMCO Corporate&Income Opportunity Fund'>PTY</a>, <a href='https://seekingalpha.com/symbol/AGG' title='iShares Core U.S. Aggregate Bond ETF'>AGG</a>, <a href='https://seekingalpha.com/symbol/BND' title='Vanguard Total Bond Market ETF'>BND</a>, <a href='https://seekingalpha.com/symbol/BOND' title='PIMCO ETF Trust - PIMCO Active Bond Exchange-Traded Fund'>BOND</a>, <a href='https://seekingalpha.com/symbol/RCS' title='PIMCO Strategic Income Fund, Inc'>RCS</a>, <a href='https://seekingalpha.com/symbol/SCHZ' title='Schwab Strategic Trust - Schwab U.S. Aggregate Bond ETF'>SCHZ</a>, <a href='https://seekingalpha.com/symbol/BTZ' title='BlackRock Credit Allocation Income Trust IV'>BTZ</a>, <a href='https://seekingalpha.com/symbol/PCM' title='PCM Fund'>PCM</a>, <a href='https://seekingalpha.com/symbol/DBL' title='Doubleline Opportunistic Credit Fund'>DBL</a>, <a href='https://seekingalpha.com/symbol/FBND' title='Fidelity Merrimack Street Trust - Fidelity Total Bond ETF'>FBND</a>, <a href='https://seekingalpha.com/symbol/IUSB' title='iShares Core Total USD Bond Market ETF'>IUSB</a>, <a href='https://seekingalpha.com/symbol/BHK' title='BlackRock Core Bond Trust'>BHK</a>, <a href='https://seekingalpha.com/symbol/SPAB' title='SPDR Portfolio Aggregate Bond ETF'>SPAB</a>, <a href='https://seekingalpha.com/symbol/JHI' title='John Hancock Investors Trust'>JHI</a>, <a href='https://seekingalpha.com/symbol/AGGY' title='WisdomTree Yield Enhanced U.S. Aggregate Bond ETF'>AGGY</a>, <a href='https://seekingalpha.com/symbol/HIPS' title='GraniteShares ETF Trust - GraniteShares HIPS US High Income ETF'>HIPS</a>, <a href='https://seekingalpha.com/symbol/PAI' title='Western Asset Income Fund'>PAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3499303\" data-linked=\"Investors re-think rate cut odds\" data-tweet=\"$PTY $AGG $BND - Investors re-think rate cut odds https://seekingalpha.com/news/3499303-investors-re-think-rate-cut-odds?source=tweet\" data-url=\"https://seekingalpha.com/news/3499303-investors-re-think-rate-cut-odds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499304\" data-ts=\"1568403509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRK\" target=\"_blank\">CRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499304-bank-of-jerry-jones-provides-unique-advantage-to-surging-comstock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Bank of Jerry Jones&#39; provides unique advantage to surging Comstock</a></h4><ul><li>Comstock Resources (<a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources, Inc.'>CRK</a> <font color='green'>+10.8%</font>) cranks out another 52-week high, capping an 80%-plus run-up since Aug. 27, as investors take a liking to the Texas oil driller that boasts an asset that rivals don't: <a href=\"https://finance.yahoo.com/news/bank-jerry-jones-could-dump-182158293.html\" target=\"_blank\">Jerry Jones' bank account</a>.</li><li>CRK management recently said Jones is not \"afraid to inject another $1.1B into the company when the opportunity presents itself,\" which would match the amount Jones already has contributed to the company over the past 18 months, according to Seaport Global analyst Mike Kelly, who says Jones' continued presence is a major positive for the driller at a time when many oil and gas firms find it difficult to access the capital markets.</li><li>Jones defended his bullish take on shale gas <a href=\"https://seekingalpha.com/news/3496991-comstock-soars-20-percent-jones-touts-covey-park-acquisition-cnbc\" target=\"_blank\">earlier this month</a>, despite the 14% slide in U.S. nat gas prices this year amid a supply glut.</li><li>Seaport reiterates a Buy rating on CRK and hikes its price target to $11 from $8, saying the driller has \"a long runway of some of the highest rate of return inventory in the space... and near unrestricted access to the Bank of Jerry Jones.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3499304\" data-linked=\"&#39;Bank of Jerry Jones&#39; provides unique advantage to surging Comstock\" data-tweet=\"$CRK - &#39;Bank of Jerry Jones&#39; provides unique advantage to surging Comstock https://seekingalpha.com/news/3499304-bank-of-jerry-jones-provides-unique-advantage-to-surging-comstock?source=tweet\" data-url=\"https://seekingalpha.com/news/3499304-bank-of-jerry-jones-provides-unique-advantage-to-surging-comstock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499291\" data-ts=\"1568400700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITVPY\" target=\"_blank\">ITVPY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499291-itv-up-liberum-suggests-divesting-sdn-buying-stv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ITV up as Liberum suggests divesting SDN, buying STV</a></h4><ul>   <li>UK broadcaster ITV (<a href=\"http://seekingalpha.com/symbol/ITVPY\" target=\"_blank\">ITVPY</a> <font color=\"green\">+4.1%</font>) is on the rise today following a note from Liberum suggesting the company could raise £750M-£1B from divesting its SDN business.</li>    <li>The company already announced the sale of its South Bank site.</li>    <li>Now cash from an SDN investment could go to debt reduction or strategic acquisition, and Liberum points to buying STV as an option there. (h/t Bloomberg)</li>    <li>The rest could go to shareholders, and (for example) a £500M buyback would be 4% accretive in fiscal 2019, the firm says.</li>    <li>Shares <font color=\"green\">rose 5.1%</font> to close out the week in London.</li>    <li>Yesterday, the company launched a <a href=\"https://seekingalpha.com/news/3498953-itv-launches-tender-500m-debt\" target=\"_blank\">tender for up to \u20ac500M in debt</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499291\" data-linked=\"ITV up as Liberum suggests divesting SDN, buying STV\" data-tweet=\"$ITVPY $ITVPF - ITV up as Liberum suggests divesting SDN, buying STV https://seekingalpha.com/news/3499291-itv-up-liberum-suggests-divesting-sdn-buying-stv?source=tweet\" data-url=\"https://seekingalpha.com/news/3499291-itv-up-liberum-suggests-divesting-sdn-buying-stv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499289\" data-ts=\"1568399742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499289-technology-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>Mer Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='Mer Telemanagement Solutions Ltd.'>MTSL</a>) <font color=\"green\">+41%</font>. Medallia (NYSE:<a href='https://seekingalpha.com/symbol/MDLA' title='Medallia, Inc.'>MDLA</a>) <font color=\"green\">+14%</font>. Super League Gaming (NASDAQ:<a href='https://seekingalpha.com/symbol/SLGG' title='Super League Gaming, Inc.'>SLGG</a>) <font color=\"green\">+12%</font>. Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+10%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Oi S.A. (NYSE:<a href='https://seekingalpha.com/symbol/OIBR.C' title='Oi S.A.'>OIBR.C</a>) <font color=\"red\">-13%</font>. Streamline Health Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a>) <font color=\"red\">-13%</font>. Park City Group (NASDAQ:<a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a>) <font color=\"red\">-12%</font>. Telaria (NYSE:<a href='https://seekingalpha.com/symbol/TLRA' title='Telaria, Inc.'>TLRA</a>) <font color=\"red\">-12%</font>. Consolidated Communications Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CNSL' title='Consolidated Communications Holdings, Inc.'>CNSL</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499289\" data-linked=\"Technology - Top 5 Gainers / Losers\" data-tweet=\"$MTSL $MDLA $SLGG - Technology - Top 5 Gainers / Losers https://seekingalpha.com/news/3499289-technology-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499289-technology-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499285\" data-ts=\"1568398700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499285-apple-denies-goldmans-tv-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple denies Goldman&#39;s TV+ claims</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) disputes the <a href=\"https://seekingalpha.com/news/3499137-goldman-cuts-apple-tv-trial\" target=\"_blank\">Goldman Sachs note</a> that says the one-year free trial for Apple TV+ with some device purchases would have a \"material negative impact\" on earnings.</li><li>Apple's statement to <a href=\"https://www.cnbc.com/2019/09/13/apple-disputes-negative-goldman-call-hitting-the-stock-says-tv-will-not-have-material-impact.html\" target=\"_blank\">CNBC</a>: \"We do not expect the introduction of Apple TV+, including the accounting treatment for the service, to have a material impact on our financial results.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3499285\" data-linked=\"Apple denies Goldman&#39;s TV+ claims\" data-tweet=\"$AAPL - Apple denies Goldman&#39;s TV+ claims https://seekingalpha.com/news/3499285-apple-denies-goldmans-tv-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/3499285-apple-denies-goldmans-tv-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>144&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499277\" data-ts=\"1568397868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499277-roan-resources-and-key-energy-services-among-energy-materials-gainers-alexco-resource-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roan Resources and Key Energy Services among Energy/Materials gainers; Alexco Resource and Independence Contract Drilling among losers</a></h4><ul><li><b>Gainers: </b>Roan Resources (NYSE:<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a>) <font color=\"green\">+11%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+11%</font>. Comstock Resources (NYSE:<a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources, Inc.'>CRK</a>) <font color=\"green\">+10%</font>. Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"green\">+8%</font>. Cimarex Energy (NYSE:<a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Alexco Resource (NYSEMKT:<a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corp.'>AXU</a>) <font color=\"red\">-9%</font>. Independence Contract Drilling (NYSE:<a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling, Inc.'>ICD</a>) <font color=\"red\">-9%</font>. China Natural Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a>) <font color=\"red\">-6%</font>. Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"red\">-6%</font>. Basic Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499277\" data-linked=\"Roan Resources and Key Energy Services among Energy/Materials gainers; Alexco Resource and Independence Contract Drilling among losers\" data-tweet=\"$ROAN $KEG $CRK - Roan Resources and Key Energy Services among Energy/Materials gainers; Alexco Resource and Independence Contract Drilling among losers https://seekingalpha.com/news/3499277-roan-resources-and-key-energy-services-among-energy-materials-gainers-alexco-resource-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3499277-roan-resources-and-key-energy-services-among-energy-materials-gainers-alexco-resource-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499274\" data-ts=\"1568395989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CURLF\" target=\"_blank\">CURLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499274-curaleaf-wins-approval-for-adult-use-licenses-in-massachusetts-shares-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Curaleaf wins approval for adult-use licenses in Massachusetts; shares gain</a></h4><ul><li>The company says the Massachusetts Cannabis Control Commission has approved thee final and two provisional adult-use licenses.</li><li>The three final adult-use licenses are: A retail license to be co-located with the current medical retail location in Oxford, and two licenses for cultivation and manufacturing.</li><li>The provisional licenses include a new retail location in Provincetown - which would be the first location on upper Cape Cod.</li><li><a href='https://seekingalpha.com/symbol/CURLF' title='Curaleaf Holdings, Inc.'>OTCPK:CURLF</a> <font color=\"green\">+2.5%</font></li><li>Source: <a href=\"https://seekingalpha.com/pr/17631872-b-curaleaf-b-receives-approval-five-adult-use-licenses-massachusetts\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3499274\" data-linked=\"Curaleaf wins approval for adult-use licenses in Massachusetts; shares gain\" data-tweet=\"$CURLF - Curaleaf wins approval for adult-use licenses in Massachusetts; shares gain https://seekingalpha.com/news/3499274-curaleaf-wins-approval-for-adult-use-licenses-in-massachusetts-shares-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3499274-curaleaf-wins-approval-for-adult-use-licenses-in-massachusetts-shares-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499272\" data-ts=\"1568394862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499272-apple-bear-sees-weak-iphone-11-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple bear sees weak iPhone 11 demand</a></h4><ul><li>Rosenblatt says Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='red'>-2.3%</font>) is seeing \"weak\" pre-orders for the iPhone 11 family, citing conversations with retailers.</li><li>Analyst Jun Zhang says \"there is no wait time today for the iPhone 11 Pro and Max\" in the United States, suggesting that initial sales could be 20-30% lower than last year's iPhone XS and Max sales.</li><li>Demand in China might also be low as companies focus on 5G models, says Zhang. On JD.com, iPhone 11 pre-orders are about 500K compared to 900K for the iPhone XR last year.</li><li>Rosenblatt maintains a Sell rating on Apple and a Street-low $150 target. Apple has an Outperform <a href=\"https://seekingalpha.com/symbol/AAPL/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499272\" data-linked=\"Apple bear sees weak iPhone 11 demand\" data-tweet=\"$AAPL - Apple bear sees weak iPhone 11 demand https://seekingalpha.com/news/3499272-apple-bear-sees-weak-iphone-11-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3499272-apple-bear-sees-weak-iphone-11-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499270\" data-ts=\"1568394746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499270-dragon-victory-international-leads-financial-gainers-mdjm-and-puyi-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dragon Victory International leads financial gainers, MDJM and Puyi among losers</a></h4><ul><li><b>Gainers:</b> Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"green\">+10%</font>. ProSight Global (NYSE:<a href='https://seekingalpha.com/symbol/PROS' title='ProSight Global, Inc.'>PROS</a>) <font color=\"green\">+7%</font>. Pzena Investment Management (NYSE:<a href='https://seekingalpha.com/symbol/PZN' title='Pzena Investment Management, Inc'>PZN</a>) <font color=\"green\">+6%</font>. Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"green\">+6%</font>. Manning &amp; Napier (NYSE:<a href='https://seekingalpha.com/symbol/MN' title='Manning & Napier, Inc.'>MN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-15%</font>. MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"red\">-10%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-8%</font>. The Progressive (NYSE:<a href='https://seekingalpha.com/symbol/PGR' title='The Progressive Corporation'>PGR</a>) <font color=\"red\">-7%</font>. A-Mark Precious Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRK' title='A-Mark Precious Metals, Inc.'>AMRK</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499270\" data-linked=\"Dragon Victory International leads financial gainers, MDJM and Puyi among losers\" data-tweet=\"$LYL $PROS $PZN - Dragon Victory International leads financial gainers, MDJM and Puyi among losers https://seekingalpha.com/news/3499270-dragon-victory-international-leads-financial-gainers-mdjm-and-puyi-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499270-dragon-victory-international-leads-financial-gainers-mdjm-and-puyi-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499266\" data-ts=\"1568394061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499266-ballard-power-systems-among-industrial-gainers-energy-recovery-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ballard Power Systems among industrial gainers; Energy Recovery only loser</a></h4><ul><li><b>Gainers: </b>Nuverra Environmental Solutions (NYSEMKT:<a href='https://seekingalpha.com/symbol/NES' title='Nuverra Environmental Solutions, Inc.'>NES</a>) <font color=\"green\">+8%</font>. Ballard Power Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems Inc.'>BLDP</a>) <font color=\"green\">+6%</font>. NN (NASDAQ:<a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a>) <font color=\"green\">+6%</font>. Parsons (NYSE:<a href='https://seekingalpha.com/symbol/PSN' title='Parsons Corporation'>PSN</a>) <font color=\"green\">+6%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Energy Recovery (NASDAQ:<a href='https://seekingalpha.com/symbol/ERII' title='Energy Recovery, Inc.'>ERII</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499266\" data-linked=\"Ballard Power Systems among industrial gainers; Energy Recovery only loser\" data-tweet=\"$NES $BLDP $NNBR - Ballard Power Systems among industrial gainers; Energy Recovery only loser https://seekingalpha.com/news/3499266-ballard-power-systems-among-industrial-gainers-energy-recovery-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3499266-ballard-power-systems-among-industrial-gainers-energy-recovery-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499267\" data-ts=\"1568393882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499267-cars-com-spikes-following-oem-news-general-motors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com spikes following OEM news with General Motors</a></h4><ul><li>Cars.com (<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a> <font color='green'>+10.7%</font>) says it has been <a href=\"https://seekingalpha.com/pr/17631828-dealer-inspire-selected-general-motors-provide-leading-edge-website-services-4000-plus-u-s\" target=\"_blank\">selected as a website provider</a> for General Motors' (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='green'>+0.3%</font>) 4K-plus  U.S.-based Chevrolet, Buick, GMC and Cadillac dealerships.</li><li>\"We first became a GM managed digital advertising vendor in October  2018, and our team is excited to now expand our offerings and deepen our  relationships with GM dealerships,\" says Joe Chura, CEO and co-founder of Cars.com's Dealer Inspire unit.</li><li>Dealer Inspire achieved an average dealer  satisfaction score of 9.5 out of 10 in 2019, the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499267\" data-linked=\"Cars.com spikes following OEM news with General Motors\" data-tweet=\"$CARS $GM - Cars.com spikes following OEM news with General Motors https://seekingalpha.com/news/3499267-cars-com-spikes-following-oem-news-general-motors?source=tweet\" data-url=\"https://seekingalpha.com/news/3499267-cars-com-spikes-following-oem-news-general-motors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499265\" data-ts=\"1568393304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499265-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers</strong>: Fibrocell Science (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) <font color=\"green\">+60%</font>. Mer Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='Mer Telemanagement Solutions Ltd.'>MTSL</a>) <font color=\"green\">+40%</font>. Francesca's Holdings Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corporation'>FRAN</a>) <font color=\"green\">+30%</font>. OpGen (NASDAQ:<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen, Inc.'>OPGN</a>) <font color=\"green\">+26%</font>. Vince Holding (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) <font color=\"green\">+24%</font>. ASLAN Pharmaceuticals Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+22%</font>. Medallia (NYSE:<a href='https://seekingalpha.com/symbol/MDLA' title='Medallia, Inc.'>MDLA</a>) <font color=\"green\">+20%</font>. Bicycle Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BCYC' title='Bicycle Therapeutics plc'>BCYC</a>) <font color=\"green\">+14%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"green\">+14%</font>. Gaia (NASDAQ:<a href='https://seekingalpha.com/symbol/GAIA' title='Gaia, Inc.'>GAIA</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers</strong>: Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) <font color=\"red\">-70%</font>. Interlink Electronics (<a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics, Inc.'>OTCPK:LINK</a>) <font color=\"red\">-23%</font>. LiveXLive Media (NASDAQ:<a href='https://seekingalpha.com/symbol/LIVX' title='LiveXLive Media, Inc.'>LIVX</a>) <font color=\"red\">-18%</font>. Dean Foods Company (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-17%</font>. Park City Group (NASDAQ:<a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a>) <font color=\"red\">-14%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-13%</font>. Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) <font color=\"red\">-14%</font>. Owens &amp; Minor (NYSE:<a href='https://seekingalpha.com/symbol/OMI' title='Owens & Minor, Inc.'>OMI</a>) <font color=\"red\">-13%</font>. Streamline Health Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a>) <font color=\"red\">-13%</font>. Adverum Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a>) <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499265\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$FCSC $MTSL $FRAN - Microcaps mostly among midday movers https://seekingalpha.com/news/3499265-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499265-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499254\" data-ts=\"1568390552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499254-dana-and-davidstea-among-consumer-gainers-dean-foods-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dana and DAVIDsTEA among consumer gainers; Dean Foods leads the losers</a></h4><ul><li><b>Gainers: </b>Vince Holding (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) <font color=\"green\">+23%</font>. Farmer Bros (NASDAQ:<a href='https://seekingalpha.com/symbol/FARM' title='Farmer Bros. Co.'>FARM</a>) <font color=\"green\">+9%</font>. Dana (NYSE:<a href='https://seekingalpha.com/symbol/DAN' title='Dana Incorporated'>DAN</a>) <font color=\"green\">+9%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"green\">+8%</font>. MasterCraft Boat (NASDAQ:<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-16%</font>. TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"red\">-7%</font>. Superior Industries International (NYSE:<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a>) <font color=\"red\">-6%</font>. Vera Bradley (NASDAQ:<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley, Inc.'>VRA</a>) <font color=\"red\">-5%</font>. The Alkaline Water (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499254\" data-linked=\"Dana and DAVIDsTEA among consumer gainers; Dean Foods leads the losers\" data-tweet=\"$VNCE $FARM $DAN - Dana and DAVIDsTEA among consumer gainers; Dean Foods leads the losers https://seekingalpha.com/news/3499254-dana-and-davidstea-among-consumer-gainers-dean-foods-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499254-dana-and-davidstea-among-consumer-gainers-dean-foods-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499255\" data-ts=\"1568390286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499255-cloudflareplus-27-after-nyse-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudflare +27% after NYSE debut</a></h4><ul><li>Cloudflare (NYSE:<a href='https://seekingalpha.com/symbol/NET' title='CloudFlare'>NET</a>) starts its first day of trading at $18 after <a href=\"https://seekingalpha.com/news/3499107-cloudflare-prices-ipo-15-high-end-range\" target=\"_blank\">pricing</a> at $15 per share, above the original $12-$14 range.</li><li>The Fastly (<a href='https://seekingalpha.com/symbol/FSLY' title='Fastly, Inc.'>FSLY</a> <font color=\"red\">-5.2%</font>) competitor raised $525M in the IPO.</li><li>NET shares are currently <font color=\"green\">up 27%</font> to $19.03.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499255\" data-linked=\"Cloudflare +27% after NYSE debut\" data-tweet=\"$NET $FSLY - Cloudflare +27% after NYSE debut https://seekingalpha.com/news/3499255-cloudflareplus-27-after-nyse-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/3499255-cloudflareplus-27-after-nyse-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499246\" data-ts=\"1568388729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EFOI\" target=\"_blank\">EFOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499246-energy-focus-down-14-post-q2-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Focus down 14% post Q2 revenue miss</a></h4><ul><li>Energy Focus (<a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a> <font color=\"red\">-14.4%</font>) reported Q2 sales declined of 40.4% Y/Y to $3.08M, driven by a 56.8% decrease in military sales period over period.</li><li>Q2 Gross loss was $109k, compare to gross profit of $1.29M a year ago.</li><li>Loss from operations expanded to $2.15M, compared to $1.8M a year ago.</li><li>Adj. EBITDA loss was $2M up from $1.45M last year same quarter.</li><li>Net cash used in operating activities was $1.56M. Cash and cash equivalents were $2.2M as of June 30, 2019.</li><li>Towards the end of the quarter, company announced a $3M contract extension with a major healthcare provider that has been customer since 2015 with over 440,000 installed Energy Focus LED lamps in their campuses.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3499156-energy-focus-eps-line-misses-revenue\" target=\"_blank\">Energy Focus EPS in-line, misses on revenue</a> (Sept. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3499246\" data-linked=\"Energy Focus down 14% post Q2 revenue miss\" data-tweet=\"$EFOI - Energy Focus down 14% post Q2 revenue miss https://seekingalpha.com/news/3499246-energy-focus-down-14-post-q2-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3499246-energy-focus-down-14-post-q2-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499245\" data-ts=\"1568388330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNMA\" target=\"_blank\">FNMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499245-new-federal-rules-to-cap-fannie-freddie-lending-for-multifamily-properties\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New federal rules to cap Fannie, Freddie lending for multifamily properties</a></h4><ul><li>The regulator of Fannie Mae (<a href='https://seekingalpha.com/symbol/FNMA' title='Federal National Mortgage Association'>OTCQB:FNMA</a> <font color=\"green\">+2.9%</font>) and Freddie Mac (<a href='https://seekingalpha.com/symbol/FMCC' title='Freddie Mac'>OTCQB:FMCC</a> <font color=\"green\">+3.3%</font>) moves to <a href=\"https://www.wsj.com/articles/trump-administration-caps-fannie-freddie-lending-for-multifamily-properties-11568382737\" target=\"_blank\">cap the amount of multifamily home loans</a> the companies can buy each year, in one of the Trump administration's first moves to revamp the companies' businesses.</li><li>The Federal Housing Finance Agency says it plans to limit purchases to $100B each and plans to eliminate exemptions from such caps for \"green\" loans - lending for energy and water efficiency improvements at multifamily properties such as smart thermostats or low-flow toilets.</li><li>The changes would mark a reversal from Obama-era policies which imposed no limits on the amount of green multifamily loans the companies could buy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499245\" data-linked=\"New federal rules to cap Fannie, Freddie lending for multifamily properties\" data-tweet=\"$FNMA $FMCC - New federal rules to cap Fannie, Freddie lending for multifamily properties https://seekingalpha.com/news/3499245-new-federal-rules-to-cap-fannie-freddie-lending-for-multifamily-properties?source=tweet\" data-url=\"https://seekingalpha.com/news/3499245-new-federal-rules-to-cap-fannie-freddie-lending-for-multifamily-properties\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499244\" data-ts=\"1568388167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499244-fda-warns-on-rare-side-effect-of-breast-cancer-meds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA warns on rare side effect of breast cancer meds</a></h4><ul><li>The FDA has issued a <a href=\"https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-severe-lung-inflammation-ibrance-kisqali-and-verzenio-breast-cancer\" target=\"_blank\">warning </a>concerning the incidence of rare severe lung inflammation in some patients receiving Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"red\">-0.8%</font>) Ibrance (palbociclib), Novartis' (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-2%</font>) Kisqali (ribociclib) or Eli Lilly's (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"red\">-0.3%</font>) Verzenio (abemaciclib), all cyclin-dependent kinase 4/6 inhibitors.</li><li>Labeling has been updated about the risk. The agency recommends that patients talk to their doctors before considering stopping treatment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499244\" data-linked=\"FDA warns on rare side effect of breast cancer meds\" data-tweet=\"$PFE $NVS $LLY - FDA warns on rare side effect of breast cancer meds https://seekingalpha.com/news/3499244-fda-warns-on-rare-side-effect-of-breast-cancer-meds?source=tweet\" data-url=\"https://seekingalpha.com/news/3499244-fda-warns-on-rare-side-effect-of-breast-cancer-meds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499242\" data-ts=\"1568387704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INGN\" target=\"_blank\">INGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499242-inogen-up-6-on-bullish-piper-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inogen up 6% on bullish Piper comments</a></h4><ul><li>Inogen (<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc.'>INGN</a> <font color=\"green\">+5.9%</font>) is up on almost a 50% surge in volume, albeit down <font color=\"red\">10%</font> from its intraday high of $55.41, in apparent response to a note from Piper Jaffray's J.P. McKim (Overweight/$80) expressing confidence in its ability to deliver double-digit growth in 2020 after meeting with management.</li><li>Shares sold off <font color=\"red\">23%</font> on August 7 after the company <a href=\"https://seekingalpha.com/news/3488439-inogen-21-percent-premarket-q2-miss-guidance-cut\" target=\"_blank\">cut its 2019 revenue outlook</a> by 9% (midpoint of guidance range). Q2 revenues were up only 4%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499242\" data-linked=\"Inogen up 6% on bullish Piper comments\" data-tweet=\"$INGN - Inogen up 6% on bullish Piper comments https://seekingalpha.com/news/3499242-inogen-up-6-on-bullish-piper-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/3499242-inogen-up-6-on-bullish-piper-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499243\" data-ts=\"1568387688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAM\" target=\"_blank\">TEAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499243-atlassianplus-1_7-bull-praises-price-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlassian +1.7% as bull praises price increase</a></h4><ul><li>William Blair\u2019s Bhavan Suri says Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a>) has increased pricing for its three larger products, which could prompt cloud customers to move to annual contracts for the discount.</li><li>The analyst says the shift could benefit billings for the next quarter or two, and notes that TEAM remains a price leader in the market.</li><li>William Blair maintains an Outperform rating. TEAM has an Outperform average <a href=\"https://seekingalpha.com/symbol/TEAM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>TEAM shares are <font color=\"green\">up 1.7%</font> to $127.63.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499243\" data-linked=\"Atlassian +1.7% as bull praises price increase\" data-tweet=\"$TEAM - Atlassian +1.7% as bull praises price increase https://seekingalpha.com/news/3499243-atlassianplus-1_7-bull-praises-price-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3499243-atlassianplus-1_7-bull-praises-price-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499240\" data-ts=\"1568387394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499240-hungary-permits-three-firms-in-5g-bidding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hungary permits three firms in 5G bidding</a></h4><ul>    <li>After expecting four or five companies to bid for 5G spectrum, Hungary has allowed three companies to take part.</li>    <li>Vodafone (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color=\"green\">+0.9%</font>), Telenor (<a href=\"http://seekingalpha.com/symbol/TELNY\" target=\"_blank\">TELNY</a> <font color=\"green\">+0.2%</font>) and Magyar Telekom (<a href=\"http://seekingalpha.com/symbol/MYTAY\" target=\"_blank\">MYTAY</a> <font color=\"green\">+8.3%</font>) are in the bidding, Bloomberg reports.</li>    <li>Hungary's telecom regulator ruled out an unspecified fourth bidder. Results will come later in the fall.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499240\" data-linked=\"Hungary permits three firms in 5G bidding\" data-tweet=\"$VOD $TELNY $MYTAY - Hungary permits three firms in 5G bidding https://seekingalpha.com/news/3499240-hungary-permits-three-firms-in-5g-bidding?source=tweet\" data-url=\"https://seekingalpha.com/news/3499240-hungary-permits-three-firms-in-5g-bidding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499235\" data-ts=\"1568387084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499235-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Fibrocell Science (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) <font color=\"green\">+60%</font>. OpGen (NASDAQ:<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen, Inc.'>OPGN</a>) <font color=\"green\">+24%</font>. ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+20%</font>. Autolus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AUTL' title='Autolus Therapeutics plc'>AUTL</a>) <font color=\"green\">+20%</font>. Digirad (NASDAQ:<a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a>) <font color=\"green\">+18%</font>.</li><li><b>Losers: </b>Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) <font color=\"red\">-71%</font>. Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) <font color=\"red\">-11%</font>. VistaGen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a>) <font color=\"red\">-10%</font>. Sintx Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SINT' title='Sintx Technologies, Inc.'>SINT</a>) <font color=\"red\">-7%</font>. PDL BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/PDLI' title='PDL BioPharma, Inc.'>PDLI</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499235\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$FCSC $OPGN $ASLN - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3499235-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499235-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499234\" data-ts=\"1568386492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LL\" target=\"_blank\">LL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499234-lumber-liquidators-too-expensive-says-founder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumber Liquidators too expensive, says founder</a></h4><ul><li>Speaking to Bloomberg, Lumber Liquidators (NYSE:<a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a>) founder Tom Sullivan says he's not interested in buying the company as the stock price has gotten too high. In fact, he says, he's planning on unloading some of his shares.</li><li>LL is <font color=\"red\">down 8.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499234\" data-linked=\"Lumber Liquidators too expensive, says founder\" data-tweet=\"$LL - Lumber Liquidators too expensive, says founder https://seekingalpha.com/news/3499234-lumber-liquidators-too-expensive-says-founder?source=tweet\" data-url=\"https://seekingalpha.com/news/3499234-lumber-liquidators-too-expensive-says-founder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499229\" data-ts=\"1568385006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RFIL\" target=\"_blank\">RFIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499229-rf-industries-slips-9-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RF Industries slips 9% post Q3 results</a></h4><ul><li>RF Industries (<a href='https://seekingalpha.com/symbol/RFIL' title='RF Industries, Ltd.'>RFIL</a> <font color=\"red\">-9.2%</font>) reported Q3 sales growth of 31.2% Y/Y to $15.5M, reflecting a full quarter of sales contribution from C Enterprises, and growth in both t traditional run rate business and project work in the OEM and wireless carrier markets.</li><li>Q3 Gross margin <font color=\"red\">declined by 663 bps</font> to 27.5%, primarily due to product mix at the Custom Cabling segment and wages for production team; and operating margin <font color=\"red\">declined by 882 bps</font> to 8.2%.</li><li>S&amp;G expenses were $2.61M (+49% Y/Y); and as percentage of sales 16.8% up by 200 bps.</li><li>Backlog was $8M at July 31, 2019 on Q3 bookings of $13.4M.</li><li>Company reported cash and cash equivalents of $13.3M, a current ratio of 6-to-1 and no outstanding debt.</li><li>Company says they will continue to execute on long-term growth plan and expect to achieve year-over-year sales growth in both Q4 and FY19, as they work toward plan of reaching $100M in sales over the next few years.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3499011-rf-industries-reports-q3-results\" target=\"_blank\">RF Industries reports Q3 results</a> (Sept. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3499226-rf-industries-declares-0_02-dividend\" target=\"_blank\">RF Industries declares $0.02 dividend</a> (Sept. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3499229\" data-linked=\"RF Industries slips 9% post Q3 results\" data-tweet=\"$RFIL - RF Industries slips 9% post Q3 results https://seekingalpha.com/news/3499229-rf-industries-slips-9-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3499229-rf-industries-slips-9-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499228\" data-ts=\"1568384513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRAD\" target=\"_blank\">DRAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499228-digirad-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digirad up 24%</a></h4><ul><li>Ultra-thinly traded nano cap Digirad (<a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color=\"green\">+24.3%</font>) is up on a whopping 111x surge in volume, albeit on turnover of 988K shares, in early trade.</li><li>This morning, it <a href=\"https://seekingalpha.com/pr/17631433-digirad-announces-listing-trading-preferred-stock-nasdaq-global-market-symbol-dradp\" target=\"_blank\">announced </a>that its newly issued 10.0% Series A Cumulative Perpetual Preferred Stock with a stated value of $10 per share is now trading on The Nasdaq Global Market under the symbol \"DRADP.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3499228\" data-linked=\"Digirad up 24%\" data-tweet=\"$DRAD - Digirad up 24% https://seekingalpha.com/news/3499228-digirad-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3499228-digirad-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499224\" data-ts=\"1568384029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANSS\" target=\"_blank\">ANSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499224-ansysplus-2-on-target-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ANSYS +2% on target boost</a></h4><ul><li>Griffin Securities upgrades ANSYS (NASDAQ:<a href='https://seekingalpha.com/symbol/ANSS' title='ANSYS, Inc.'>ANSS</a>) from Neutral to Buy with a $240 target, a 14% upside.</li><li>The investment banking firm expects ANSYS to remain the market leader by revenue in simulation software.</li><li>ANSYS shares are <font color=\"green\">up 2%</font> to $215.39. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/ANSS/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499224\" data-linked=\"ANSYS +2% on target boost\" data-tweet=\"$ANSS - ANSYS +2% on target boost https://seekingalpha.com/news/3499224-ansysplus-2-on-target-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3499224-ansysplus-2-on-target-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499222\" data-ts=\"1568383674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499222-fda-alerts-on-zantac-contamination\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA alerts on Zantac contamination</a></h4><ul><li>The FDA is <a href=\"https://www.fda.gov/news-events/press-announcements/statement-alerting-patients-and-health-care-professionals-ndma-found-samples-ranitidine\" target=\"_blank\">alerting </a>the public that certain ranitidine medicines, including Zantac, contain low levels of a carcinogen called NDMA. The agency is investigating the matter, adding that it is not advising consumers to stop taking the drugs at this time.</li><li>Related tickers: Sanofi (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color=\"red\">-0.3%</font>), ANI Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a> <font color=\"green\">+0.5%</font>), Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-1.5%</font>), Dr. Reddy's Laboratories (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"red\">-0.9%</font>); Amneal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a> <font color=\"red\">-0.6%</font>), Mylan (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a>), Teligent (<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color=\"green\">+1.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3499222\" data-linked=\"FDA alerts on Zantac contamination\" data-tweet=\"$SNY $ANIP $ENDP - FDA alerts on Zantac contamination https://seekingalpha.com/news/3499222-fda-alerts-on-zantac-contamination?source=tweet\" data-url=\"https://seekingalpha.com/news/3499222-fda-alerts-on-zantac-contamination\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499214\" data-ts=\"1568382952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499214-juul-reported-to-be-lower-on-secondary-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juul reported to be lower on secondary market</a></h4><ul> <li>The valuation on Juul (<a href='https://seekingalpha.com/symbol/JUUL' title='JUUL'>JUUL</a>) is down to around $225 to $230 per share in the secondary market following this week's vaping focus from the government, according to reporting by CNBC's David Faber.</li> <li>Altria (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='red'>-1.3%</font>) stepped in to take its 35% stake in Juul at a level of about $250 per share on the secondary market.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3499214\" data-linked=\"Juul reported to be lower on secondary market\" data-tweet=\"$JUUL $MO - Juul reported to be lower on secondary market https://seekingalpha.com/news/3499214-juul-reported-to-be-lower-on-secondary-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3499214-juul-reported-to-be-lower-on-secondary-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>113&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499209\" data-ts=\"1568382042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499209-auris-clarifies-endpoint-for-phase-2-3-study-of-keyzilen-for-tinnitus-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auris clarifies endpoint for Phase 2/3 study of Keyzilen for tinnitus; shares up 3%</a></h4><ul><li>Auris Medical Holding (<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding Ltd.'>EARS</a> <font color=\"green\">+3.4%</font>) <a href=\"https://seekingalpha.com/pr/17631653-auris-medical-receives-fda-ema-guidance-keyzilen-late-stage-clinical-development-program\" target=\"_blank\">announces </a>that the FDA and EMA are both on board with the use of the Tinnitus Functional Index &#40;TFI&#41; as the primary efficacy endpoint for its planned Phase 2/3 clinical trial evaluating Keyzilen (AM-101) in patients with the chronic ear-ringing condition.</li><li>The two regulators also agreed on less frequent collection of patient-reported tinnitus loudness compared to previous trials where daily ratings were difficult to gather. The FDA considers the improvement in tinnitus loudness as a co-primary endpoint while the EMA considers it a secondary endpoint.</li><li>The company says it plans to support the continued development of Keyzilen with non-dilutive funding. Options include strategic partnering, special purpose vehicle financing, grant funding or a combination thereof.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499209\" data-linked=\"Auris clarifies endpoint for Phase 2/3 study of Keyzilen for tinnitus; shares up 3%\" data-tweet=\"$EARS - Auris clarifies endpoint for Phase 2/3 study of Keyzilen for tinnitus; shares up 3% https://seekingalpha.com/news/3499209-auris-clarifies-endpoint-for-phase-2-3-study-of-keyzilen-for-tinnitus-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3499209-auris-clarifies-endpoint-for-phase-2-3-study-of-keyzilen-for-tinnitus-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499203\" data-ts=\"1568381260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUV\" target=\"_blank\">LUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499203-macquarie-sees-upside-on-southwest-airlines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macquarie sees upside on Southwest Airlines</a></h4><ul> <li>Macquarie says it's adding Southwest Airlines (NYSE:<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a>) to its list of Outperform-rated airline stocks that includes United Airlines, Delta Air Lines and Allegiant Travel.</li> <li>\"We think that the airline will now be able to fully utilize its new revenue management system and more efficiently schedule its aircraft as the MAX's are ungrounded and reintroduced into their system,\" updates analyst Susan Donofrio.</li> <li>\"We also like Southwest\u2019s move to join Travelport and Amadeus Travel Platforms global distribution systems as we think that it gives the airline a new growth platform with small to medium businesses,\" she adds.</li><li>Macquarie lifts its price target on LUV to $67 off a 14.0X earnings multiple vs. old price target of $52 and 12.0X multiple. The sell-side consensus PT on Southwest is down to $58.21.</li> <li>Shares of LUV are <font color=\"green\">up 1.29%</font> premarket to $55.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499203\" data-linked=\"Macquarie sees upside on Southwest Airlines\" data-tweet=\"$LUV - Macquarie sees upside on Southwest Airlines https://seekingalpha.com/news/3499203-macquarie-sees-upside-on-southwest-airlines?source=tweet\" data-url=\"https://seekingalpha.com/news/3499203-macquarie-sees-upside-on-southwest-airlines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499201\" data-ts=\"1568380751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499201-sdrl-mnk-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SDRL, MNK among premarket gainers</a></h4><ul><li>Mer Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='Mer Telemanagement Solutions Ltd.'>MTSL</a>) <font color=\"green\">+96%</font> on <a href=\"https://seekingalpha.com/news/3499055-mer-telemanagement-reports-1h-results\" target=\"_blank\">1H results</a>.</li><li>Fibrocell Science, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) <font color=\"green\">+60%</font> on <a href=\"https://seekingalpha.com/news/3499114-fibrocell-64-percent-premarket-castle-creek-bid\" target=\"_blank\">Castle Creek bid</a>.</li><li>Cellectar Biosciences, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+14%</font>.</li><li>Mallinckrodt plc (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/news/3499121-mallinckrodt-analysis-shows-cost-effectiveness-acthar-gel-late-line-ms-relapses\" target=\"_blank\">cost-effectiveness</a> of Acthar Gel for late-line MS relapses.</li><li>Bitauto Holdings(NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) <font color=\"green\">+12%</font> on Tencent <a href=\"https://seekingalpha.com/news/3499168-bitauto-plus-12-percent-tencent-go-private-offer\" target=\"_blank\">go-private offer</a>.</li><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3499106-catalyst-pharma-discontinue-stock-offering-shares-10-percent-premarket\" target=\"_blank\">discontinuing stock offering</a>.</li><li>PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3499196-pg-and-e-reaches-11b-settlement-california-wildfire-claims\" target=\"_blank\">$11B settlement</a> on California wildfire claims.</li><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"green\">+7%</font>.</li><li>Ideanomics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDEX' title='Ideanomics, Inc.'>IDEX</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/pr/17631585-ideanomics-mobile-energy-group-petro-china-announces-strategic-partnership-develop-clean\" target=\"_blank\">strategic partnership</a> with the China National Petroleum.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499201\" data-linked=\"SDRL, MNK among premarket gainers\" data-tweet=\"$MTSL $FCSC $CLRB - SDRL, MNK among premarket gainers https://seekingalpha.com/news/3499201-sdrl-mnk-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499201-sdrl-mnk-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499200\" data-ts=\"1568380732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNCE\" target=\"_blank\">VNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499200-vince-holdingsplus-19-after-above-consensus-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vince Holdings +19% after above-consensus guidance</a></h4><ul> <li>Vince Holdings (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) pops after setting favorable <a href=\"https://seekingalpha.com/news/3499017-vince-beats-revenue\" target=\"_blank\">guidance</a> amid the tough tariff scenario.</li> <li>The company expects full-year revenue of $295M to $305M vs. $290M to $300M prior view and $297M consensus.</li> <li>Vince delved into the tariff issue on the post-earnings conference call (<a href=\"https://seekingalpha.com/article/4291296-vince-holding-corp-vnce-ceo-brendan-hoffman-q2-2019-results-earnings-call-transcript\" target=\"_blank\">transcript</a>). \"We have been implementing mitigation efforts, including accelerating shipments which we started in the second quarter and continue negotiations with our vendors, who have been good partners in working with us on pricing,\" stated CEO Brendan Hoffman.</li> <li>Shares of Vince are <font color=\"green\">up 18.80%</font> premarket to $13.65.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499200\" data-linked=\"Vince Holdings +19% after above-consensus guidance\" data-tweet=\"$VNCE - Vince Holdings +19% after above-consensus guidance https://seekingalpha.com/news/3499200-vince-holdingsplus-19-after-above-consensus-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3499200-vince-holdingsplus-19-after-above-consensus-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499199\" data-ts=\"1568380550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499199-treasurys-give-up-ground-after-strong-retail-sales-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasurys give up more ground after strong retail sales print</a></h4><ul><li>August retail sales topped expectations, rising 0.4% vs. 0.2% expected. July's print was upwardly revised to a 0.8% gain.</li><li>\"Control group\" sales gained 0.3%, matching expectations, but again, July's advance was revised higher.</li><li>Continuing an ugly month, bonds sold off hard on the news, with the 10-year Treasury yield jumping another six basis points to 1.836%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"red\">-1.05%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"green\">+2.1%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3499199\" data-linked=\"Treasurys give up more ground after strong retail sales print\" data-tweet=\"$TLT $TBT - Treasurys give up more ground after strong retail sales print https://seekingalpha.com/news/3499199-treasurys-give-up-ground-after-strong-retail-sales-print?source=tweet\" data-url=\"https://seekingalpha.com/news/3499199-treasurys-give-up-ground-after-strong-retail-sales-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499198\" data-ts=\"1568380303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499198-mcf-rttr-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MCF, RTTR among premarket losers</a></h4><ul><li>Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) <font color=\"red\">-72%</font> after RP-G28 <a href=\"https://seekingalpha.com/news/3499051-ritter-pharmas-rp-g28-flunks-late-stage-study\" target=\"_blank\">flunks</a> late-stage study.</li><li>Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"red\">-20%</font> on <a href=\"https://seekingalpha.com/news/3499105-contango-prices-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) <font color=\"red\">-12%</font> after FDA's decision on <a href=\"https://seekingalpha.com/news/3499003-fda-oks-ardelyxs-tenapanor-ibs-c\" target=\"_blank\">tenapanor</a> for IBS-C.</li><li>Sintx Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SINT' title='Sintx Technologies, Inc.'>SINT</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499198\" data-linked=\"MCF, RTTR among premarket losers\" data-tweet=\"$RTTR $MCF $ARDX - MCF, RTTR among premarket losers https://seekingalpha.com/news/3499198-mcf-rttr-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3499198-mcf-rttr-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499196\" data-ts=\"1568379981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499196-pg-and-e-reaches-11b-settlement-on-california-wildfire-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E reaches $11B settlement on California wildfire claims</a></h4><ul><li>PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"green\">+8.4%</font> pre-market after announcing an <a href=\"https://seekingalpha.com/pr/17631618-second-major-settlement-pg-and-e-reaches-agreement-principle-resolve-insurance-subrogation\" target=\"_blank\">$11B agreement in principle</a> with groups representing ~85% of insurance subrogation claims related to the 2017 northern California wildfires and the 2018 Camp Fire.</li><li>PG&amp;E reaffirms the total $14B equity financing commitment  target for its reorganization plan, and says it has received  $1.5B in renewed commitments and intends to seek remaining equity financing commitments over the  next several weeks.</li><li>The settlement is subject to approval of the Bankruptcy Court overseeing PG&amp;E's Chapter 11 case, and follows a $1B settlement reached in June with 18 local public entities.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499196\" data-linked=\"PG&amp;E reaches $11B settlement on California wildfire claims\" data-tweet=\"$PCG - PG&amp;E reaches $11B settlement on California wildfire claims https://seekingalpha.com/news/3499196-pg-and-e-reaches-11b-settlement-on-california-wildfire-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/3499196-pg-and-e-reaches-11b-settlement-on-california-wildfire-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499168\" data-ts=\"1568378944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499168-bitautoplus-12-on-tencent-go-private-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto +12% on Tencent go-private offer</a></h4><ul><li>Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>)<a href=\"https://seekingalpha.com/pr/17631580-bitauto-announces-receipt-preliminary-non-binding-going-private-proposal\" target=\"_blank\"> received</a> a preliminary non-binding proposal letter from Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holdings Limited'>OTCPK:TCEHY</a>,<a href='https://seekingalpha.com/symbol/TCTZF' title='Tencent Holdings Limited'>OTCPK:TCTZF</a>) and Hammer Capital  to acquire all shares not already owned by the group.</li><li>The purchase offer is $16 in cash per ADS.</li><li>BITA says the board is forming an independent committee to consider the offer to go private.</li><li>BITA shares are <font color=\"green\">up 11.7%</font> pre-market to $15.36.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499168\" data-linked=\"Bitauto +12% on Tencent go-private offer\" data-tweet=\"$BITA $TCEHY $TCTZF - Bitauto +12% on Tencent go-private offer https://seekingalpha.com/news/3499168-bitautoplus-12-on-tencent-go-private-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3499168-bitautoplus-12-on-tencent-go-private-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499166\" data-ts=\"1568378898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTX\" target=\"_blank\">AKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499166-akari-therapeutics-up-12-premarket-on-orphan-drug-tag-for-nomacopan-for-bp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akari Therapeutics up 12% premarket on Orphan Drug tag for Nomacopan for BP</a></h4><ul> <li>The FDA has <a href=\"https://seekingalpha.com/pr/17631554-akari-therapeutics-nomacopan-granted-u-s-orphan-drug-designation-bullous-pemphigoid\" target=\"_blank\">granted</a> Orphan Drug Designation to Akari Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a>) nomacopan for the treatment of bullous pemphigoid &#40;BP&#41;.</li><li>Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.</li>     <li>Shares are up <font color=\"green\">12%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3499166\" data-linked=\"Akari Therapeutics up 12% premarket on Orphan Drug tag for Nomacopan for BP\" data-tweet=\"$AKTX - Akari Therapeutics up 12% premarket on Orphan Drug tag for Nomacopan for BP https://seekingalpha.com/news/3499166-akari-therapeutics-up-12-premarket-on-orphan-drug-tag-for-nomacopan-for-bp?source=tweet\" data-url=\"https://seekingalpha.com/news/3499166-akari-therapeutics-up-12-premarket-on-orphan-drug-tag-for-nomacopan-for-bp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499157\" data-ts=\"1568377905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNLI\" target=\"_blank\">DNLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499157-leerink-likes-acadia-pharma-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink likes Acadia Pharma in premarket analyst action</a></h4><ul><li>Denali Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/DNLI' title='Denali Therapeutics Inc.'>DNLI</a>) initiated with Buy rating and $35 (84% upside) price target at Nomura Instinet.</li><li>Intuitive Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a>) initiated with Buy rating at Redburn.</li><li>ACADIA Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>) upgraded to Outperform with a $50 (28% upside) price target at SVB Leerink. Shares up <font color=\"green\">2% </font>premarket.</li><li>PRA Health Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/PRAH' title='PRA Health Sciences, Inc.'>PRAH</a>) upgraded to Overweight with a $118 (16% upside) price target at KeyBanc.</li><li>Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) downgraded to Neutral with a $1 (8% upside) price target at Citigroup. Shares down <font color=\"red\">3%</font> premarket.</li><li>Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) downgraded to Neutral at Alliance Global Partners. Shares down <font color=\"red\">74%</font> premarket after lead candidate failed late-stage study.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499157\" data-linked=\"Leerink likes Acadia Pharma in premarket analyst action\" data-tweet=\"$DNLI $ISRG $ACAD - Leerink likes Acadia Pharma in premarket analyst action https://seekingalpha.com/news/3499157-leerink-likes-acadia-pharma-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3499157-leerink-likes-acadia-pharma-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499152\" data-ts=\"1568377134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRO\" target=\"_blank\">FRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499152-frontlineplus-3-after-btig-bump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontline +3% after BTIG bump</a></h4><ul> <li>Frontline (NYSE:<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a>) is higher in early trading after BTIG upgrades to the shipping company a Buy rating from Neutral off confidence in the tanker market.</li> <li>BTIG sets a price target of $12 to rep 38% upside potential and stand well-above the 52-week high of $9.54 and <a href=\"https://seekingalpha.com/symbol/FRO/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $9.78.</li> <li>Shares of Frontline are <font color=\"green\">up 3.33%</font> premarket to $9.01.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499152\" data-linked=\"Frontline +3% after BTIG bump\" data-tweet=\"$FRO - Frontline +3% after BTIG bump https://seekingalpha.com/news/3499152-frontlineplus-3-after-btig-bump?source=tweet\" data-url=\"https://seekingalpha.com/news/3499152-frontlineplus-3-after-btig-bump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499151\" data-ts=\"1568376866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499151-biogen-and-eisai-bail-on-alzheimers-candidate-elenbecestat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen and Eisai bail on Alzheimer&#39;s candidate elenbecestat</a></h4><ul><li>Citing an unfavorable risk-benefit relationship, Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) and collaboration partner Eisai (<a href='https://seekingalpha.com/symbol/ESALY' title='Eisai Co., Ltd.'>OTCPK:ESALY</a>) had decided to <a href=\"https://seekingalpha.com/pr/17631541-eisai-biogen-discontinue-phase-iii-clinical-studies-bace-inhibitor-elenbecestat-early\" target=\"_blank\">terminate </a>Phase 3 studies evaluating BACE inhibitor elenbecestat for the potential treatment of patients with early-stage Alzheimer's disease. Detailed data will be submitted for presentation at future medical conferences.</li><li>The companies also <a href=\"https://seekingalpha.com/news/3444728-biogen-eisai-bail-aducanumab-alzheimers\" target=\"_blank\">came up empty</a> with amyloid beta-targeting aducanumab. They terminated late-stage development in March due to lack of efficacy.</li><li>BIIB is down <font color=\"red\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499151\" data-linked=\"Biogen and Eisai bail on Alzheimer&#39;s candidate elenbecestat\" data-tweet=\"$BIIB $ESALY - Biogen and Eisai bail on Alzheimer&#39;s candidate elenbecestat https://seekingalpha.com/news/3499151-biogen-and-eisai-bail-on-alzheimers-candidate-elenbecestat?source=tweet\" data-url=\"https://seekingalpha.com/news/3499151-biogen-and-eisai-bail-on-alzheimers-candidate-elenbecestat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499124\" data-ts=\"1568373714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMT\" target=\"_blank\">AIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499124-aimmune-shares-halted-for-ad-com-review-of-ar101-application\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aimmune shares halted for Ad Com review of AR101 application</a></h4><ul><li>Nasdaq has suspended trading in Aimmune Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics, Inc.'>AIMT</a>) while an FDA advisory committee meets today to review and discuss its marketing application for Palforzia (formerly AR101) to reduce the incidence and severity of allergic reactions to peanut in young people aged 4 - 17 who have a confirmed diagnosis of peanut allergy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499124\" data-linked=\"Aimmune shares halted for Ad Com review of AR101 application\" data-tweet=\"$AIMT - Aimmune shares halted for Ad Com review of AR101 application https://seekingalpha.com/news/3499124-aimmune-shares-halted-for-ad-com-review-of-ar101-application?source=tweet\" data-url=\"https://seekingalpha.com/news/3499124-aimmune-shares-halted-for-ad-com-review-of-ar101-application\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499122\" data-ts=\"1568373385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEM\" target=\"_blank\">KEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499122-kemetplus-2_8-stifel-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kemet +2.8% as Stifel turns bullish</a></h4><ul><li>Stifel upgrades Kemet (NYSE:<a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corporation'>KEM</a>) from Hold to Buy and stays at a $26 target, a 41% upside.</li><li>Last month, KEM reported Q1 beats with 5% Y/Y revenue growth.</li><li>Kemet shares are <font color=\"green\">up 2.8%</font> pre-market to $18.97. The company has a Buy average <a href=\"https://seekingalpha.com/symbol/KEM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499122\" data-linked=\"Kemet +2.8% as Stifel turns bullish\" data-tweet=\"$KEM - Kemet +2.8% as Stifel turns bullish https://seekingalpha.com/news/3499122-kemetplus-2_8-stifel-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3499122-kemetplus-2_8-stifel-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499120\" data-ts=\"1568373237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499120-etsyplus-3-after-wedbush-joins-bull-camp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Etsy +3% after Wedbush joins bull camp</a></h4><ul> <li>Wedbush upgrades Etsy (NASDAQ:<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a>) to an Outperform rating from Neutral on its view that gross merchandise sales growth will continue to be strong and margins will improve.</li> <li>The firm lifts its price target to $66 vs. the 52-week trading range of $38.02 to $73.34 and the average sell-side PT of $76.14. 11 of 15 firms covering Etsy have a Buy-equivalent rating on the e-commerce stock.</li> <li>Shares of Etsy are <font color=\"green\">up 3.04%</font> premarket to $56.55.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3499120\" data-linked=\"Etsy +3% after Wedbush joins bull camp\" data-tweet=\"$ETSY - Etsy +3% after Wedbush joins bull camp https://seekingalpha.com/news/3499120-etsyplus-3-after-wedbush-joins-bull-camp?source=tweet\" data-url=\"https://seekingalpha.com/news/3499120-etsyplus-3-after-wedbush-joins-bull-camp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499114\" data-ts=\"1568372209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCSC\" target=\"_blank\">FCSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499114-fibrocell-up-64-premarket-on-castle-creek-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fibrocell up 64% premarket on Castle Creek bid</a></h4><ul><li>Fibrocell Science (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) is up <font color=\"green\">64%</font> premarket on light volume in reaction to its agreement to be <a href=\"https://seekingalpha.com/pr/17631313-castle-creek-pharmaceutical-holdings-announces-agreement-acquire-fibrocell\" target=\"_blank\">acquired </a>by collaboration partner Castle Creek Pharmaceutical Holdings for an undisclosed sum.</li><li>Both companies are developing therapies to treat a rare skin disorder called epidermolysis bullosa.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499114\" data-linked=\"Fibrocell up 64% premarket on Castle Creek bid\" data-tweet=\"$FCSC - Fibrocell up 64% premarket on Castle Creek bid https://seekingalpha.com/news/3499114-fibrocell-up-64-premarket-on-castle-creek-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3499114-fibrocell-up-64-premarket-on-castle-creek-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499113\" data-ts=\"1568371873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STSA\" target=\"_blank\">STSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499113-satsuma-prices-ipo-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Satsuma prices IPO at $15</a></h4><ul> <li>Satsuma Pharmaceuticals (<a href='https://seekingalpha.com/symbol/STSA' title='Satsuma Pharmaceuticals'>STSA</a>) has <a href=\"https://seekingalpha.com/pr/17631340-satsuma-pharmaceuticals-inc-announces-pricing-initial-public-offering-common-stock\" target=\"_blank\">priced</a> its initial public offering of 5.5M common shares at $15.00/share, for gross proceeds of $82.5M.</li><li>Underwriters over-allotment is an additional 825,000 shares.</li><li>Trading kicks off today.</li><li>Closing date is September 17.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3496246-satsuma-pharma-sets-ipo-terms\" target=\"_blank\">Satsuma Pharma sets IPO terms</a> (Sept. 3)</li><li><strong>Update</strong>: Shares opened at $19.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3499113\" data-linked=\"Satsuma prices IPO at $15\" data-tweet=\"$STSA - Satsuma prices IPO at $15 https://seekingalpha.com/news/3499113-satsuma-prices-ipo-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3499113-satsuma-prices-ipo-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499106\" data-ts=\"1568370481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499106-catalyst-pharma-to-discontinue-stock-offering-shares-up-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma to discontinue stock offering; shares up 10% premarket</a></h4><ul> <li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) is up <font color=\"green\">10%</font> premarket on the heels of the <a href=\"https://seekingalpha.com/pr/17631450-catalyst-pharmaceuticals-inc-determines-proceed-previously-announced-public-offering-common\" target=\"_blank\">announcement</a> to terminate its common stock offering.</li><li>The Company believes that the culmination of an offering at the current market price is not in the best interest of the Company and its stockholders.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3498714-catalyst-11-percent-hours-stock-offering\" target=\"_blank\">Catalyst down 11% after hours on stock offering</a> (Sept. 11)</li>       </ul><div class=\"tiny-share-widget\" data-id=\"3499106\" data-linked=\"Catalyst Pharma to discontinue stock offering; shares up 10% premarket\" data-tweet=\"$CPRX - Catalyst Pharma to discontinue stock offering; shares up 10% premarket https://seekingalpha.com/news/3499106-catalyst-pharma-to-discontinue-stock-offering-shares-up-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3499106-catalyst-pharma-to-discontinue-stock-offering-shares-up-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3499096\" data-ts=\"1568367402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3499096-dow-and-s-and-p-closing-in-on-records\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dow and S&amp;P closing in on records</a></h4><ul><li>The Dow this session is looking to surpass an intraday record high of 27,398.68, while the S&amp;P 500 is closing in on its previous record of 3,027.98, as the rally continues with stock index futures <font color=\"green\">ahead by 0.2%</font>.</li><li>Leading the rise is new round of bond-buying at the ECB, positive developments on the U.S.-China trade front, and a tame inflation reading Thursday morning that cleared the way for a Fed rate cut next week.</li><li>U.S. Treasury bond yields are also extending their seemingly-relentless advance, topping the 1.8% mark in early European trading to reach their highest level since late July.</li></ul><div class=\"tiny-share-widget\" data-id=\"3499096\" data-linked=\"Dow and S&amp;P closing in on records\" data-tweet=\"Dow and S&amp;P closing in on records https://seekingalpha.com/news/3499096-dow-and-s-and-p-closing-in-on-records?source=tweet\" data-url=\"https://seekingalpha.com/news/3499096-dow-and-s-and-p-closing-in-on-records\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":52,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}